PITTSBURGH, PA / ACCESSWIRE / March 31, 2020 / Liberated Syndication (OTCQB:LSYN) ("Libsyn"), a world leading podcast hosting network, announced today that it has filed a Form 12b-25, Notification of Late Filing, with the Securities and Exchange Commission that will provide the Company with a 15 calendar-day extension beyond the March 30th, 2020 deadline within which to file the annual report on Form 10-K.

Libsyn will delay its earnings press release and shareholder conference call to discuss 2019 financial results, previously scheduled for March 30th, 2020 and April 1, 2020 at 11:00 a.m. ET, respectively. The Company will announce a new date for the shareholder conference call at the appropriate time.

About Liberated Syndication

Libsyn, a world leading podcast hosting network and has been providing publishers with distribution and monetization services since 2004. In 2018, Libsyn delivered over 5.1 Billion downloads. Libsyn hosts over 5.6 Million media files from more than 67,000 podcasts, including typically around 35% of the top 200 podcasts in Apple Podcasts. Podcast producers choose Libsyn to measure their audience via IAB V2 certified stats, deliver popular audio and video episodes, distribute their content through smartphone Apps (iOS, and Android), and monetize via premium subscription services and advertising. We are a Pittsburgh based company with a world class team. Visit us on the web at www.libsyn.com.

Pair Networks, founded in 1996, is one of the oldest and most experienced Internet hosting company providing a full range of fast, powerful and reliable Web hosting services. Pair offers a suite of Internet services from shared hosting to virtual private servers to customized solutions with world-class 24×7 on-site customer support. Based in Pittsburgh, Pair serves businesses, bloggers, artists, musicians, educational institutions and non-profit organizations around the world. Visit us on the web at www.pair.com.

Legal Notice

"Forward-looking Statements" as defined in the Private Securities litigation Reform Act of 1995 may be included in some of the information or materials made available on this website. These statements relate to future events or our future financial performance. These statements are only predictions and may differ materially from actual future results or events. We disclaim any intention or obligation to revise any forward-looking statements whether as a result of new information, future developments or otherwise, except as required by law. There are important risk factors that could cause actual results to differ from those contained in forward-looking statements, including, but not limited to, risks associated with our change in business strategy towards more heavy reliance upon on our new talent segment and wholesale channels, actions of regulators concerning our business operations or trading markets for our securities, the extent to which we are able to develop new services and markets for our services, our significant reliance on third parties to distribute our content, the level of demand and market

acceptance of our services and the "Risk Factors" set forth in our most recent SEC filings.

Investor Relations Contact

Laurie Sims
investor@libsyn.com
https://investor.libsyn.com

SOURCE: Liberated Syndication

ReleaseID: 583364

In 1900, 194 of every 100,000 US residents died from Tuberculosis.

FULTON, MD / ACCESSWIRE / March 31, 2020 / In 1931, a small yet mighty group of American Pest professionals-donned in gas masks-fumigated a Washington D.C. hotel for Tuberculosis. By 1940, before the introduction of antibiotic therapy, TB remained the leading cause of death. Today, achievements in Public Health, including sanitation and pest control, save millions of lives across the globe.

Amid a global pandemic, mid-Atlantic based American Pest traipses back to its roots to bring Disinfectant and Sanitizing treatments to life-with a modern solution to controlling and preventing the spread of infectious diseases-furthering the company's commitment to integrity, public health, and the environment.

"The company we are today was founded in 1925 as American Disinfectant Company," says David Billingsly, President of American Pest. "We've always been extremely proud of our company history and longstanding commitment to protecting public health and property. It's the absolute right thing to do amidst the COVID-19 crisis-to once again provide safe, effective disinfectant and sanitizing services to the public."

American Pest leverages the experience of tenured Ph.D Entomologists and Board Certified Entomologists on its staff to develop, test and deliver high-efficacy pest control and sanitation programs from the organization's lab in Fulton, Maryland.

"Our expert selection of broad-spectrum disinfectant is EPA-approved for effective elimination of viruses and designed to sanitize environmental surfaces," says W. Wayne White, B.C.E., VP of Technical Services. "Using specialized misting equipment, we can disinfect and sanitize large areas in a short time."

In response to an increased need for sanitizing services, the company will launch its American Disinfectant Service this week. Home and business owners facing disruptions from the Coronavirus outbreak across the District of Columbia, Maryland, and Virginia will have access to priority scheduling and after-hours treatment options.

American Pest, an Anticimex company and homeland-security approved Essential Business, is committed to the health and safety of our employees and clients. As a good corporate citizen, we protect public health and property for more than 40,000 homes and businesses and millions of square feet of office space throughout the District of Columbia, Maryland, and Virginia.

For immediate release:

Miranda Sherman
American Pest
Dir: 301.252.2741
americanpest.net

SOURCE: American Pest

ReleaseID: 583342

RADNOR, PA / ACCESSWIRE / March 31, 2020 / The law firm of Kessler Topaz Meltzer & Check, LLP reminds investors that a securities fraud class action lawsuit has been filed in the United States District Court for the Eastern District of Pennsylvania against Inovio Pharmaceuticals, Inc. (NASDAQ:INO) ("Inovio") on behalf of those who purchased or otherwise acquired Inovio common stock between February 14, 2020 and March 9, 2020, inclusive (the "Class Period").

Important Deadline: Investors who purchased or otherwise acquired Inovio common stock during the Class Period may, no later than May 12, 2020, seek to be appointed as a lead plaintiff representative of the class. For additional information or to learn how to participate in this litigation please click https://www.ktmc.com/inovio-pharmaceuticals-securities-class-action?utm_source=PR&utm_medium=link&utm_campaign=inovio.

According to the complaint, Inovio is a biotechnology company focused on rapidly bringing to market precisely designed DNA medicines to treat, cure and/or protect people from infectious diseases. The worldwide outbreak of the novel coronavirus, COVID-19, has become a global "pandemic" due to its extraordinary speed and scale of transmission. According to the World Health Organization ("WHO") Director-General, the WHO is deeply concerned by both the alarming levels of spread and severity of COVID-19. During the Class Period, the defendants capitalized on widespread COVID-19 fears by falsely claiming that Inovio had developed a vaccine for COVID-19.

The Class Period commences on February 14, 2020, when Inovio Chief Executive Officer, J. Joseph Kim ("Kim"), appeared on Fox Business News with Neal Cavuto, and stated that Inovio had developed a COVID-19 vaccine "in a matter of about three hours once we had the DNA sequence from the virus" and "our goal is to start phase one human testing in the U.S. early this summer." In response, Inovio's stock price rose more than 10% over the next few trading days. Two weeks later, following a well-publicized March 2, 2020 meeting with President Donald J. Trump to discuss the COVID-19 outbreak, Kim again claimed that Inovio had developed a COVID-19 vaccine, stating "we were able to fully construct our vaccine within three hours . . . . Our plan is to start [U.S. based COVID-19 trials] in April of this year." The market responded favorably to Kim's statement and Inovio's stock price more than quadrupled from $4.28 per share on February 28, 2020, and continued to increase in the following weeks, reaching an intra-day high of $19.36 on March 9, 2020.

According to the complaint, on March 9, 2020, before trading commenced, Citron Research ("Citron") exposed the defendants' misstatements, calling for an SEC investigation into Inovio's "ludicrous and dangerous claim that they designed a [COVID-19] vaccine in 3 hours." Following this news, Inovio's stock price plummeted from its March 9 opening price of $18.72 per share to close at $9.83. On March 10, 2020, Inovio's stock price fell from its $9.30 per share opening price to close at $5.70 per share. The two-day drop wiped out approximately $643 million in market capitalization for Inovio, marking a 71% decline from its Class Period high. In a message to shareholders that same day, Inovio attempted to blunt the Citron revelations, but only highlighted its own misstatements, admitting that it had not developed a COVID-19 vaccine but rather had merely "designed a vaccine construct" – i.e., a precursor for a vaccine – and that it believed it had a "viable approach to address the COVID-19 outbreak."

The complaint alleges that, throughout the Class Period, the defendants falsely: (1) described their product as a fully completed vaccine when it was nothing of the sort; (2) claimed they had developed the vaccine in a matter of hours, which is a scientific impossibility; and (3) stated that they would be able to begin human trials in April 2020 when they had no reason to believe that they would have the necessary regulatory approvals to do so.

If you wish to discuss this securities fraud class action lawsuit or have any questions concerning this notice or your rights or interests with respect to this litigation, please contact Kessler Topaz Meltzer & Check (James Maro, Jr., Esq. or Adrienne Bell, Esq.) at (844) 877-9500 (toll free) or (610) 667-7706, or via e-mail at info@ktmc.com.

Inovio investors may, no later than May 12, 2020, seek to be appointed as a lead plaintiff representative of the class through Kessler Topaz Meltzer & Check, or other counsel, or may choose to do nothing and remain an absent class member. A lead plaintiff is a representative party who acts on behalf of all class members in directing the litigation. In order to be appointed as a lead plaintiff, the Court must determine that the class member's claim is typical of the claims of other class members, and that the class member will adequately represent the class. Your ability to share in any recovery is not affected by the decision of whether or not to serve as a lead plaintiff.

Kessler Topaz Meltzer & Check prosecutes class actions in state and federal courts throughout the country involving securities fraud, breaches of fiduciary duties and other violations of state and federal law. Kessler Topaz Meltzer & Check is a driving force behind corporate governance reform, and has recovered billions of dollars on behalf of institutional and individual investors from the United States and around the world. The firm represents investors, consumers and whistleblowers (private citizens who report fraudulent practices against the government and share in the recovery of government dollars). The complaint in this action was not filed by Kessler Topaz Meltzer & Check. For more information about Kessler Topaz Meltzer & Check, please visit www.ktmc.com.

CONTACT:

Kessler Topaz Meltzer & Check, LLP
James Maro, Jr., Esq.
Adrienne Bell, Esq.
280 King of Prussia Road
Radnor, PA 19087
(844) 877-9500 (toll free)
(610) 667-7706
info@ktmc.com

SOURCE: Kessler Topaz Meltzer & Check, LLP

ReleaseID: 583290

HOUSTON, TX / ACCESSWIRE / March 31, 2020 / On March 30, 2020, PEDEVCO Corp. (NYSE American:PED) ("PEDEVCO" or the "Company") reported its year-end results for 2019, and today announced new efforts initiated to reduce operating and corporate costs.

Over the year-ended December 31, 2019, the Company generated nearly $13 million in gross oil and gas revenue from the production and sale of 266,070 barrels of oil equivalent ("BOE") from its Permian Basin and D-J Basin assets, representing a 186% increase in both year-over-year production and revenues, with a corresponding direct lease operating expense ("LOE") increase of only 122%, demonstrating efficiencies of cost and scale as the Company significantly increased its production. These production increases were largely attributable to new wells completed and brought on-line in the Company's Permian Basin asset in late spring 2019, with the Company anticipating LOE to drop significantly in 2020 through operational efficiencies. In addition, the Company reported $0.644 million in net cash flow provided by operating activities before changes in working capital, which is the first time the Company has had positive cash flow in over 10 years. In addition, the Company's total estimated proved reserves as estimated by the independent petroleum engineering firm of Cawley, Gillespie & Associates grew from 12.4 million BOE at the year-ended December 31, 2018, to over 14.0 million BOE at the year-ended December 31, 2019, of which 12.4 million barrels are crude oil.

The Company also has initiated significant G&A cost-reduction measures, including a reduction to all employee salaries by 20% until market conditions significantly improve, cutting all discretionary spending, and undertaking additional actions resulting in a nearly 30% aggregate G&A reduction in 2020. Additionally, the Company is taking cost-reduction measures anticipated to reduce LOE by over 30% in 2020. Unless market conditions significantly improve through the year, the Company plans to pause its planned 2020 development plan, with the only anticipated significant capital expenditures in 2020 being those related to 2019 carryover capital commitments.

Dr. Simon Kukes, the Chief Executive Officer of the Company, commented, "We believe our year-end results demonstrate the strength of our assets and their growth potential as we continue to unlock the value of our Permian Basin and D-J Basin asset positions through further development. We are uniquely positioned with zero debt, nearly $10 million of free cash on hand, and the ability to slow or halt most of our current development projects to weather the current down market. We believe our strong asset base and balance sheet, together with the cost-cutting measures being implemented now, will put us in an excellent position when the market recovers to resume our full development plan and potentially acquire additional assets from companies which are under extremely heavy distress in the current environment."

About PEDEVCO Corp.

PEDEVCO Corp. (NYSE American: PED), is a publicly-traded energy company engaged in the acquisition and development of strategic, high growth energy projects in the United States. The Company's principal assets are its San Andres Asset located in the Northwest Shelf of the Permian Basin in eastern New Mexico, and its D-J Basin Asset located in the D-J Basin in Weld and Morgan Counties, Colorado. PEDEVCO is headquartered in Houston, Texas.

Cautionary Statement Regarding Forward Looking Statements

All statements in this press release that are not based on historical fact are "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995 and the provisions of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended (the "Acts"). In particular, when used in the preceding discussion, the words "estimates," "believes," "hopes," "expects," "intends," "plans," "anticipates," or "may," and similar conditional expressions are intended to identify forward-looking statements within the meaning of the Act, and are subject to the safe harbor created by the Act. Any statements made in this news release other than those of historical fact, about an action, event or development, are forward-looking statements. While management has based any forward-looking statements contained herein on its current expectations, the information on which such expectations were based may change. These forward-looking statements rely on a number of assumptions concerning future events and are subject to a number of risks, uncertainties, and other factors, many of which are outside of the Company's control, that could cause actual results to materially differ from such statements. Such risks, uncertainties, and other factors include, but are not necessarily limited to, those set forth under Item 1A "Risk Factors" in the Company's Annual Report on Form 10-K for the year ended December 31, 2019 and subsequently filed Quarterly Reports on Form 10-Q under the heading "Risk Factors". The Company operates in a highly competitive and rapidly changing environment, thus new or unforeseen risks may arise. Accordingly, investors should not place any reliance on forward-looking statements as a prediction of actual results. The Company disclaims any intention to, and undertakes no obligation to, update or revise any forward-looking statements, except as otherwise required by law, and also takes no obligation to update or correct information prepared by third parties that are not paid for by the Company. Readers are also urged to carefully review and consider the other various disclosures in the Company's public filings with the Securities Exchange Commission (SEC).

Contacts

PEDEVCO Corp.
1-855-733-3826
PR@pedevco.com

SOURCE: PEDEVCO Corp.

ReleaseID: 583173

VANCOUVER, BC / ACCESSWIRE / March 31, 2020 / CanaFarma Hemp Products Corp. (CSE:CNFA)(formerly KYC Technology Inc.) (the "Corporation" or "CanaFarma") announces that Frank Barone Jr. and Kirill Chumenko have tendered their resignations as directors of the Corporation, though both will continue to retain their executive officer roles (Mr. Barone as Sales & Marketing Senior Vice President, and Mr. Chumenko as Senior Vice President). The Corporation expresses its thanks to both gentlemen for their service on the board from the time of formation of CanaFarma Corp. through the completion of the RTO and listing on the CSE.

David Lonsdale, CEO of CanaFarma commented: "Frank and Kirill have done a great job of helping the Corporation through its formation and public listing process and we look forward to their future contributions in their operating roles."

About CanaFarma Hemp Products Corp.

CanaFarma Hemp is a full-service company operating in the hemp industry offering a full range of hemp-related products and services. These products and services include growing top-quality hemp, providing

hemp-processing services, and offering hemp-based products to consumers utilizing a direct-to-consumer marketing approach.

CAUTIONARY STATEMENT REGARDING FORWARD-LOOKING INFORMATION: This news release includes certain "forward-looking statements" under applicable Canadian securities legislation. Forward-looking statements include, but are not limited to, statements with respect to future developments and the business and operations of the Corporation. Forward-looking statements are necessarily based upon a number of estimates and assumptions that, while considered reasonable, are subject to known and unknown risks, uncertainties, and other factors which may cause the actual results and future events to differ materially from those expressed or implied by such forward-looking statements. Such factors include, but are not limited to general business, economic, competitive, political and social uncertainties; and delay or failure to receive board, shareholder or regulatory approvals. Readers should not place undue reliance on forward-looking statements. The Corporation disclaims any intention or obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as required by law.

FOR FURTHER INFORMATION, PLEASE CONTACT:

David Lonsdale
Chief Executive Officer,
Phone: (214) 704-7942
Email: david@canafarmacorp.com

SOURCE: CanaFarma Hemp Products Corp.

ReleaseID: 583362

NEW YORK, NY / ACCESSWIRE / March 31, 2020 / The securities litigation law firm of The Gross Law Firm issues the following notice on behalf of shareholders in the following publicly traded companies. Shareholders who purchased shares in the following companies during the dates listed are encouraged to contact the firm regarding possible Lead Plaintiff appointment. Appointment as Lead Plaintiff is not required to partake in any recovery.

Jeld-Wen Holding, Inc. (NYSE:JELD)

Investors Affected : January 26, 2017 – October 15, 2018

A class action has commenced on behalf of certain shareholders in Jeld-Wen Holding, Inc. The filed complaint alleges that defendants made materially false and/or misleading statements and/or failed to disclose that: (1) the Company's products, including doors, did not compete against other manufacturers on price, contrary to Jeld-Wen's representations; (2) the market in which the Company sells its doors is not "highly competitive" as the Company claimed; (3) Jeld-Wen's strong margins and anticipated margin growth were not, as the Company claimed, attributed to changes they had made in Jeld-Wen's business operations and strategies; and (4) Jeld-Wen failed to disclose the Company's anti competitive conduct. Because of the foregoing, Defendants' statements about the Company's business, operations and prospects lacked a reasonable basis.

Shareholders may find more information at https://securitiesclasslaw.com/securities/jeld-wen-holding-inc-loss-submission-form/?id=5868&from=1

MGP Ingredients, Inc. (NASDAQ:MGPI)

Investors Affected : February 27, 2019 – February 25, 2020

A class action has commenced on behalf of certain shareholders in MGP Ingredients, Inc. The filed complaint alleges that defendants made materially false and/or misleading statements and/or failed to disclose that: (a) MGP had not completed any significant sales of its four-year-old aged whiskey inventory; (b) the Company had been unable to sell its aged whiskey at the price premium represented to investors; (c) a glut of aged whiskey inventory and shifts in consumer behavior had lowered the value of the Company's aged whiskey inventory and materially impaired its ability to negotiate significant sales on favorable contract terms; and (d) in light of the foregoing, the Company's FY19 financial forecast lacked a reasonable basis and was materially misleading.

Shareholders may find more information at https://securitiesclasslaw.com/securities/mgp-ingredients-inc-loss-submission-form/?id=5868&from=1

Tilray, Inc. (NASDAQ:TLRY)

Investors Affected : January 15, 2019 – March 2, 2020

A class action has commenced on behalf of certain shareholders in Tilray, Inc. The filed complaint alleges that defendants made materially false and/or misleading statements and/or failed to disclose that: (i) the purported advantages of the marketing and revenue sharing agreement with Authentic Brands Group (the "ABG Agreement")were significantly overstated; (ii) the under performance of the ABG Agreement would foreseeably have a significant impact on the Company's financial results; and (iii) as a result, the Company's public statements were materially false and misleading at all relevant times.

Shareholders may find more information at https://securitiesclasslaw.com/securities/tilray-inc-loss-submission-form/?id=5868&from=1

The Gross Law Firm is committed to ensuring that companies adhere to responsible business practices and engage in good corporate citizenship. The firm seeks recovery on behalf of investors who incurred losses when false and/or misleading statements or the omission of material information by a Company lead to artificial inflation of the Company's stock. Attorney advertising. Prior results do not guarantee similar outcomes.

CONTACT:
The Gross Law Firm
15 West 38th Street, 12th floor
New York, NY, 10018
Email: dg@securitiesclasslaw.com
Phone: (212) 537-9430
Fax: (833) 862-7770

SOURCE: The Gross Law Firm

ReleaseID: 583363

NEW YORK, NY / ACCESSWIRE / March 31, 2020 / PaySign, Inc. (NASDAQ:PAYS) will be discussing their earnings results in their 2019 Fourth Quarter Earnings call to be held on March 31, 2020 at 5:00 PM Eastern Time.

To listen to the event live or access a replay of the call – visit
https://www.investornetwork.com/event/presentation/60823

To receive updates for this company you can register by emailing info@investornetwork.com or by clicking get investment info from the company's profile.

About Investor Network

Investor Network (IN) is a financial content community, serving millions of unique investors market information, earnings, commentary and news on what's trending. Dedicated to both the professional and the average traders, IN offers timely, trusted and relevant financial information for virtually every investor. IN is an Issuer Direct brand, to learn more or for the latest financial news and market information, visit www.investornetwork.com. Follow us on Twitter @investornetwork.

SOURCE: Investor Network

ReleaseID: 583232

NEW YORK, NY / ACCESSWIRE / March 31, 2020 / Babcock & Wilcox Enterprises, Inc. (NYSE:BW) will be discussing their earnings results in their 2019 Fourth Quarter Earnings call to be held on March 31, 2020 at 5:00 PM Eastern Time.

To listen to the event live or access a replay of the call – visit
https://www.investornetwork.com/event/presentation/60990

To receive updates for this company you can register by emailing info@investornetwork.com or by clicking get investment info from the company's profile.

About Investor Network

Investor Network (IN) is a financial content community, serving millions of unique investors market information, earnings, commentary and news on what's trending. Dedicated to both the professional and the average traders, IN offers timely, trusted and relevant financial information for virtually every investor. IN is an Issuer Direct brand, to learn more or for the latest financial news and market information, visit www.investornetwork.com. Follow us on Twitter @investornetwork.

SOURCE: Investor Network

ReleaseID: 583230

CORAL GABLES, FL / ACCESSWIRE / March 31, 2020 / The top website for all things penny stocks, PennyStocks.com just released a new, exclusive & informative article titled: Are Penny Stocks Worth It? 4 To Watch This Week. The team at PennyStocks.com discusses 4 penny stocks trading higher on the last day of March 2020.

Within this article, PennyStocks.com states how: "The markets are trading with a bit of chop today. There hasn't been a defined directional move even amid upbeat economic data from China. But that hasn't stopped penny stocks from producing big gains so far. In our morning update, several of the penny stocks mentioned managed to soar over 100% with many continuing to trade higher. But what does that mean for the rest of the week?"

The top site for all things penny stocks continues: "Volatility is here for the time being and trading penny stocks is one of the best ways to take advantage of that volatility. What's more, is that it doesn't necessarily matter what's happening in the broader markets either. Many small-cap and micro-cap stocks tend to break out even if the markets are tanking. In any case, the point is that you should have a plan and strategy in place. In light of this, we've got a list of penny stocks to watch including SG Blocks, Inc. (NASDAQ:SGBX)."

Read the article from PennyStocks.com titled: Are Penny Stocks Worth It? 4 To Watch This Week<<

Penny Stocks (PennyStocks.com)

PennyStocks.com is the best place to find the top penny stocks to buy, a full list of penny stocks and small cap stock news, articles & information. Penny stocks are off to a very strong start in 2020 and are expected to continue their bullish run. Subscribe, to our Free Penny Stocks Newsletter and stay updated on the top penny stock picks, exclusive articles & small cap stock alerts.

Contact:

Name: Adam Lawrence
Email: news@pennystocks.com
Phone: (305) 204-3247

Legal Disclaimer

Except for the historical information presented herein, matters discussed in this article contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. MIDAM VENTURES LLC, which owns www.PennyStocks.com is not registered with any financial or securities regulatory authority and does not provide nor claims to provide investment advice or recommendations to readers of this release. Please Read Our Full Disclosure Located Here: https://pennystocks.com/disclaimer/

SOURCE: PennyStocks.com

ReleaseID: 583302